44 min
Alix Turoff MS, RD, CDN, CPT | Let's talk about Ozempic Alix Turoff Nutrition Podcast
-
- Nutrition
Episode 89: Alix Turoff MS, RD, CDN, CPT | Let's talk about Ozempic Show Notes: On this episode of the Alix Turoff Nutrition podcast, Alix is back with a new season! She starts the season off with a bang by talking about the medication that’s on everyone’s mind… Ozempic. She also discussed Mounjaro (tirzepatide). She’s talking about everything from how these medications work, who they might be appropriate for, and the social media storm surrounding them.
Research:
Semaglutide for the treatment of obesity
Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients with Type 2 Diabetes: The PIONEER 8 Trial
Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss
Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension
Safety of Semaglutide
Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial
Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses
Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials
Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5
Semaglutide for the treatment of overweight and obesity: A review
Two-year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: STEP 5
Clinical Impact of Semaglutide, a Glucagon-Like Peptide-1 Receptor Agonist, on Obesity Management: A Review
The Health at Every Size Paradigm and Obesity: Missing Empirical Evidence May Help Push the Reframing Obesity Debate Forward
Resources:
Submit your questions for upcoming podcast episodes
Get the 5 week Flexible Nutrition Starter Kit
Apply for Alix’s 12 week small group coaching program
Apply for Alix’s 1:1 coaching program
Follow Alix on Instagram
Join Alix’s private Facebook group
Download your FREE Happy Hour Survival Guide
Buy Alix’s book on Amazon
Shop my favorite products on Amazon
Contact Alix via email
Be sure you’re subscribed to this podcast to automatically receive your episodes!!!
If you enjoyed today’s episode, I’d love it if you would take a minute to leave a rating and review!
Subscribe to The Alix Turoff Nutrition Podcast
Discount Codes:
Built Bar: Use the code ALIX for 10% off your order
Legion Athletics: Use the code Alix for 20% off your order
Episode 89: Alix Turoff MS, RD, CDN, CPT | Let's talk about Ozempic Show Notes: On this episode of the Alix Turoff Nutrition podcast, Alix is back with a new season! She starts the season off with a bang by talking about the medication that’s on everyone’s mind… Ozempic. She also discussed Mounjaro (tirzepatide). She’s talking about everything from how these medications work, who they might be appropriate for, and the social media storm surrounding them.
Research:
Semaglutide for the treatment of obesity
Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients with Type 2 Diabetes: The PIONEER 8 Trial
Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss
Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension
Safety of Semaglutide
Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial
Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses
Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials
Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5
Semaglutide for the treatment of overweight and obesity: A review
Two-year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: STEP 5
Clinical Impact of Semaglutide, a Glucagon-Like Peptide-1 Receptor Agonist, on Obesity Management: A Review
The Health at Every Size Paradigm and Obesity: Missing Empirical Evidence May Help Push the Reframing Obesity Debate Forward
Resources:
Submit your questions for upcoming podcast episodes
Get the 5 week Flexible Nutrition Starter Kit
Apply for Alix’s 12 week small group coaching program
Apply for Alix’s 1:1 coaching program
Follow Alix on Instagram
Join Alix’s private Facebook group
Download your FREE Happy Hour Survival Guide
Buy Alix’s book on Amazon
Shop my favorite products on Amazon
Contact Alix via email
Be sure you’re subscribed to this podcast to automatically receive your episodes!!!
If you enjoyed today’s episode, I’d love it if you would take a minute to leave a rating and review!
Subscribe to The Alix Turoff Nutrition Podcast
Discount Codes:
Built Bar: Use the code ALIX for 10% off your order
Legion Athletics: Use the code Alix for 20% off your order
44 min